loadpatents
name:-0.028174161911011
name:-0.013985157012939
name:-0.005605936050415
Auer; Johannes Patent Filings

Auer; Johannes

Patent Applications and Registrations

Patent applications and USPTO patent grants for Auer; Johannes.The latest application filed is for "method for the generation of a bivalent, bispecific antibody expressing cell by targeted integration of multiple expression cassettes in a defined organization".

Company Profile
5.14.29
  • Auer; Johannes - Schwaigen DE
  • AUER; Johannes - Penzberg DE
  • Auer; Johannes - Schwaigen OT Grafenaschau DE
  • Auer, Johannes - Grafenaschau DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For The Generation Of A Bivalent, Bispecific Antibody Expressing Cell By Targeted Integration Of Multiple Expression Cassettes In A Defined Organization
App 20220169730 - Auer; Johannes ;   et al.
2022-06-02
Method For The Generation Of A Trivalent Antibody Expressing Cell By Targeted Integration Of Multiple Expression Cassettes In A Defined Organization
App 20220169729 - Auer; Johannes ;   et al.
2022-06-02
Method For The Generation Of A Multivalent, Bispecific Antibody Expressing Cell By Targeted Integration Of Multiple Expression Cassettes In A Defined Organization
App 20220169731 - Auer; Johannes ;   et al.
2022-06-02
Method for producing monomeric and multimeric molecules and uses thereof
Grant 11,254,728 - Auer , et al. February 22, 2
2022-02-22
Method For The Generation Of A Multivalent, Multispecific Antibody Expressing Cells By Targeted Integration Of Multiple Expression Cassettes In A Defined Organization
App 20210139561 - AUER; Johannes ;   et al.
2021-05-13
Three-dimensional Structure-based Humanization Method
App 20200223945 - AUER; Johannes ;   et al.
2020-07-16
Method For Producing Monomeric And Multimeric Molecules And Uses Thereof
App 20200157183 - Auer; Johannes ;   et al.
2020-05-21
Method for producing monomeric and multimeric molecules and uses thereof
Grant 10,570,188 - Auer , et al. Feb
2020-02-25
Anti-brdu Antibodies And Methods Of Use
App 20200002437 - Brinkmann; Ulrich ;   et al.
2020-01-02
TNFa-IL-17 bispecific antibodies
Grant 10,329,346 - Auer , et al.
2019-06-25
Method For Producing Monomeric And Multimeric Molecules And Uses Thereof
App 20170342128 - Auer; Johannes ;   et al.
2017-11-30
Bispecific antibodies against human TWEAK and human IL17 and uses thereof
Grant 9,714,292 - Auer , et al. July 25, 2
2017-07-25
Bispecific Antigen Binding Molecules
App 20170198043 - Auer; Johannes ;   et al.
2017-07-13
Anti-brdu Antibodies And Methods Of Use
App 20170114150 - BRINKMANN; Ulrich ;   et al.
2017-04-27
Tnfa-il-17 Bispecific Antibodies
App 20160326241 - AUER; JOHANNES ;   et al.
2016-11-10
Humanized anti-CDCP1 antibodies
Grant 9,346,886 - Auer , et al. May 24, 2
2016-05-24
Method For Producing Monomeric And Multimeric Molecules And Uses Thereof
App 20150218250 - Auer; Johannes ;   et al.
2015-08-06
Bispecific Antibodies Against Human Tweak And Human 1l17 And Uses Thereof
App 20150132307 - AUER; JOHANNES ;   et al.
2015-05-14
Humanized Anti-CDCP1 Antibodies
App 20130209455 - Auer; Johannes ;   et al.
2013-08-15
Antibodies Against Human Il17 And Uses Thereof
App 20130195844 - Auer; Johannes ;   et al.
2013-08-01
Humanized anti-CDCP1 antibodies
Grant 8,394,928 - Auer , et al. March 12, 2
2013-03-12
Bispecific antigen binding molecules
App 20130058937 - Auer; Johannes ;   et al.
2013-03-07
Antibodies specifically binding to human TSLPR and methods of use
App 20120020988 - AUER; JOHANNES ;   et al.
2012-01-26
Antibodies against human IL17 and uses thereof
Grant 8,003,099 - Auer , et al. August 23, 2
2011-08-23
Humanized Anti-CDCP1 Antibodies
App 20110052582 - Auer; Johannes ;   et al.
2011-03-03
Method for the recombinant expression of an N-terminal fragment of hepatocyte growth factor
Grant 7,754,448 - Auer , et al. July 13, 2
2010-07-13
Antibodies against human IL17 and uses thereof
App 20100080812 - Auer; Johannes ;   et al.
2010-04-01
Afucosylated antibodies against CCR5 and their use for the treatment of inflammatory conditions
App 20090226434 - Auer; Johannes ;   et al.
2009-09-10
Antibodies against CCR5 and uses thereof
App 20090110686 - Auer; Johannes ;   et al.
2009-04-30
Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
App 20080319165 - Muller; Hans Werner ;   et al.
2008-12-25
Method for the recombinant expression of an n-terminal fragment of hepatocyte growth factor
App 20070154985 - Auer; Johannes ;   et al.
2007-07-05
Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof
Grant 7,214,532 - Stern , et al. May 8, 2
2007-05-08
Preparation of erythropoietin by endogenous gene activation
Grant 7,186,529 - Stern , et al. March 6, 2
2007-03-06
Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof
App 20040203001 - Stern, Anne ;   et al.
2004-10-14
Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
App 20030215792 - Muller, Hans Werner ;   et al.
2003-11-20
Preparation of erythropoietin by endogenous gene activation
App 20030166275 - Stern, Anne ;   et al.
2003-09-04
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
Grant 6,548,296 - Stern , et al. April 15, 2
2003-04-15
Preparation of erythropoietin by endogenous gene activation
Grant 6,544,748 - Stern , et al. April 8, 2
2003-04-08
Preparation of erythropoietin by endogenous gene activation
App 20020110913 - Stern, Anne ;   et al.
2002-08-15
Production of erythropoietin by endogenous gene activation
Grant 6,391,633 - Stern , et al.
2002-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed